NEWTOWN, Pa., Dec. 22, 2004--R&D Directions’ The Drug Development Summit, sponsored by RPS, Inc.; eResearch Technologies, Inc.; Averion; AAPP, and PharmaLive.com, brings together heads of research and development from the industry’s leading pharmaceutical and biotechnology companies to speak on the state of the industry and their own organization’s discovery and development activity. The Drug Development Summit is a R&D conference with a proven record of delivering the most senior executives from the top pharmaceutical companies. Conference faculty will include senior representatives from Amgen, Inc.; AstraZeneca; Avalon Pharmaceuticals, Inc.; Catalyst Law Group, APC; Eli Lilly and Company; Millennium Pharmaceuticals; Roche; National Institute of Health; Novartis; Wyeth; Bioscience Ventures, Inc.; and, Johnson & Johnson.
